Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy

Neurology

Volumn 75, Issue 15, 2010, Pages 1377-1380

  Harbo, Thomas ^a   Andersen, Henning ^a   Jakobsen, Johannes ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; SUBCUVIA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE SWELLING; LONG TERM CARE; MAINTENANCE THERAPY; MALE; MOTOR DYSFUNCTION; MOTOR NEUROPATHY; MOTOR PERFORMANCE; MULTIFOCAL MOTOR NEUROPATHY; MUSCLE FUNCTION; MUSCLE STRENGTH; PATIENT AUTONOMY; PRIORITY JOURNAL; PRURITUS; PSYCHOLOGICAL RATING SCALE; SKIN MANIFESTATION; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 77958561737     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181f735ce     Document Type: Article

References (10)

1. van Schaik IN, Van den Berg LH, de Haan R, Vermeulen M. Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database Syst Rev 2005;18: CD004429.
2. Vucic S, Black KR, Chong PS, Cros D. Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg. Neurology 2004;63:1264-1269. (Pubitemid 39350028)
3. Nicolay U, Kiessling P, Berger M, et al. Health-related quality of life and treatment satisfaction in North American patients with primary immune deficiency diseases receiving subcutaneous IgG self-infusions at home. J Clin Immunol 2006;26:65-72. (Pubitemid 43112626)
4. Harbo T, Andersen H, Hess A, Hansen K, Sindrup SH, Ja-kobsen J. Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial. Eur J Neurol 2009;16:631-638.
5. van Schaik I, Bouche P, Illa I, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol 2006;13:802-808. (Pubitemid 44124675)
6. Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2002;72:596-601.
7. Harbo T, Andersen H, Jakobsen J. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2009;39:439-447.
8. Koller H, Schroeter M, Feischen H, Hartung HP, Kieseier BC. Subcutaneous self-infusions of immunoglobulins as a potential therapeutic regimen in immune-mediated neuropathies. J Neurol 2006;253:1505-1506. (Pubitemid 44950287)
9. Lee DH, Linker RA, Paulus W, Schneider-Gold C, Chan A, Gold R. Subcutaneous immunoglobulin infusion: A new therapeutic option in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2007;37: 406-409. (Pubitemid 351304803)
10. Eftimov F, Vermeulen M, de Haan RJ, Van den Berg LH, van Schaik. Subcutaneous immunoglobulin therapy for multifocal motor neuropathy. J Peripher Nerv Syst 2009; 14:93-100.